Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013–2018

Table 1 Procedure codes used to identify genetic testing

Genetic testing categories	Description	CPT-4/HCPCS codes
HBOC syndrome testing	BRCA1/2	81162, 81163, 81164, 81165, 81166, 81167, 81211, 81212, 81213, 81214, 81215, 81216, 81217
HBOC syndrome testing	Panel	81432, 81433, 0102U, 0103U, 0129U, 0131U, 0132U, 0133U, 0138U
Lynch syndrome testing	Individual genes	81292, 81293, 81294, 81295, 81296, 81297, 81298, 81299, 81300, 81317, 81318, 81319
Lynch syndrome testing	Panel	0130U, 0162U
Other HCS panel testing	Hereditary polyposis genes	81201, 81202, 81203
	Multiple endocrine neoplasia panel	81437, 81438
	Cowden syndrome/PTEN	81321, 81322, 81323
	Hereditary multicancer panel	0104U, 0134U, 0135U, 81435, 81436
Tier 2 molecular pathology procedures^a		81403, 81404, 81405, 81406, 81408, 81479

HBOC Hereditary Breast and Ovarian Cancer
CPT-4 Current Procedural Terminology-4
HCPCS Healthcare Common Procedure Coding System
HCS Hereditary cancer syndrome
^a Tier 2 molecular pathology procedures are based on the complexity of the testing technique and are not specific to a gene or hereditary cancer syndrome.

ISSN: 1897-4287